(PharmaNewsWire.Com, March 31, 2017 ) Market Data Forecast recently published a report on the North America Colorectal Cancer Market which estimates the market to grow from USD 4.51 billion from 2016 to USD 5.03 billionwith a high CAGR of 2.21 %. Though there is an extensive progress in technology and science to combat cancer, It always continues to threaten people across the globe. It is the 3rd most common cancer and is becoming the dreadful reality for many others.
The DROC Analysis contains some of the factors that have major effects on the market dynamics be it positive or negative. Few factors analysed in the section are rise in pipeline colorectal cancer aging population, screening tests, increasing awareness, and government policies. High cost of screening test is a restricting the growth of market.
The treatments are segmented based on Diagnosis and Treatment and studied for a deep-level understanding of the Diagnostic Imaging market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Product Segmentation:
1) Based on Diagnosis:
Digital Rectal Examination Faecal Occult Blood Test Flexible Sigmoidoscopy Colonoscopy Virtual Colonoscopy
2) Based on Treatment:
Surgery and Radiation Therapy Chemotherapy Targeted Therapies Resistance to Pharmacological Therapies
North American Market is studied in geographic perspective by segregating the market shares between USA and Canada. The study identifies USA as the predominant market in the North American region and it holds well in the Global Market too. As per the report, companies like Abbott Diagnostics, Beckman Coulter, Companion Dx, Debiopharm Group, Alere, Clinical Genomics, Hoffmann La Roche, Vaccinogen BD.
Scope of the North America Colorectal Cancer Market:
Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region
To detect major focus areas of industrial growth Segment-level analysis on basis of Diagnosis and treatment along with market size forecasts and y-o-y estimations are provided
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
PESTLE and Porters Five Forces Analysesthat examine themacro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
Anextensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
Expertly devised Market Outlookcomprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the clients research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
